Follistatin 344 (1mg)
ā¢ Composition and format
Ā Ā Ā Ā Follistatin 344 (1 mg) is a recombinant peptide supplied as a lyophilized powder in a single vial. Each vial contains 1 mg of Follistatin 344. The batch-specific Certificate of Analysis (COA) provides protein sequence confirmation, molecular weight verification, and formulation details to support method-level reproducibility and documentation control in research environments.
Ā Ā
ā¢ Analytical verification
Ā Ā Ā Ā Each lot is qualified at 95%+ purity by high-performance liquid chromatography; protein identity and structural integrity are confirmed by mass spectrometry. Independent third-party laboratories corroborate in-house analytical results to maintain traceable quality metrics appropriate for research use.
Ā Ā
ā¢ Intended research use
Ā Ā Ā Ā Follistatin 344 is evaluated exclusively in controlled in-vitro systems investigating activin-binding interactions, growth factor signaling pathways, and cellular differentiation models under defined assay conditions. All technical communications are method-centric and do not imply diagnostic, therapeutic, performance, or clinical outcomes in humans or animals.
Ā Ā
ā¢ Research characteristics and applications
Ā Ā Ā Ā Follistatin 344 is characterized by a defined protein structure with high affinity for members of the transforming growth factor-beta (TGF-Ī²) superfamily. In controlled in-vitro environments, researchers employ Follistatin 344 to study ligand-binding dynamics, signaling pathway modulation, and regulatory interactions involving activins and related proteins. Representative applications include assay development, mechanistic pathway investigations, concentration-response analyses, and cellular signaling characterization strictly within laboratory settings.
Ā Ā
ā¢ Manufacturing and documentation
Ā Ā Ā Ā Alpha BioMed Labs manufactures this material in the United States under defined quality procedures and research-only labeling. Certificates of Analysis, raw-material sourcing from vetted suppliers, and complete batch documentation are maintained to support institutional procurement review, traceability, and audit readiness.
Ā Ā
Research Use Only (RUO) Statement
Ā Ā Ā Ā ā¢ For in-vitro research only
Ā Ā Ā Ā ā¢ Not for human or animal consumption
Ā Ā Ā Ā ā¢ Not for diagnostic or therapeutic use
Ā Ā
Follistatin 344 (1mg)
ā¢ Composition and format
Ā Ā Ā Ā Follistatin 344 (1 mg) is a recombinant peptide supplied as a lyophilized powder in a single vial. Each vial contains 1 mg of Follistatin 344. The batch-specific Certificate of Analysis (COA) provides protein sequence confirmation, molecular weight verification, and formulation details to support method-level reproducibility and documentation control in research environments.
Ā Ā
ā¢ Analytical verification
Ā Ā Ā Ā Each lot is qualified at 95%+ purity by high-performance liquid chromatography; protein identity and structural integrity are confirmed by mass spectrometry. Independent third-party laboratories corroborate in-house analytical results to maintain traceable quality metrics appropriate for research use.
Ā Ā
ā¢ Intended research use
Ā Ā Ā Ā Follistatin 344 is evaluated exclusively in controlled in-vitro systems investigating activin-binding interactions, growth factor signaling pathways, and cellular differentiation models under defined assay conditions. All technical communications are method-centric and do not imply diagnostic, therapeutic, performance, or clinical outcomes in humans or animals.
Ā Ā
ā¢ Research characteristics and applications
Ā Ā Ā Ā Follistatin 344 is characterized by a defined protein structure with high affinity for members of the transforming growth factor-beta (TGF-Ī²) superfamily. In controlled in-vitro environments, researchers employ Follistatin 344 to study ligand-binding dynamics, signaling pathway modulation, and regulatory interactions involving activins and related proteins. Representative applications include assay development, mechanistic pathway investigations, concentration-response analyses, and cellular signaling characterization strictly within laboratory settings.
Ā Ā
ā¢ Manufacturing and documentation
Ā Ā Ā Ā Alpha BioMed Labs manufactures this material in the United States under defined quality procedures and research-only labeling. Certificates of Analysis, raw-material sourcing from vetted suppliers, and complete batch documentation are maintained to support institutional procurement review, traceability, and audit readiness.
Ā Ā
Research Use Only (RUO) Statement
Ā Ā Ā Ā ā¢ For in-vitro research only
Ā Ā Ā Ā ā¢ Not for human or animal consumption
Ā Ā Ā Ā ā¢ Not for diagnostic or therapeutic use
Ā Ā
Product Information
Product Information
Shipping & Returns
Shipping & Returns
Description
ā¢ Composition and format
Ā Ā Ā Ā Follistatin 344 (1 mg) is a recombinant peptide supplied as a lyophilized powder in a single vial. Each vial contains 1 mg of Follistatin 344. The batch-specific Certificate of Analysis (COA) provides protein sequence confirmation, molecular weight verification, and formulation details to support method-level reproducibility and documentation control in research environments.
Ā Ā
ā¢ Analytical verification
Ā Ā Ā Ā Each lot is qualified at 95%+ purity by high-performance liquid chromatography; protein identity and structural integrity are confirmed by mass spectrometry. Independent third-party laboratories corroborate in-house analytical results to maintain traceable quality metrics appropriate for research use.
Ā Ā
ā¢ Intended research use
Ā Ā Ā Ā Follistatin 344 is evaluated exclusively in controlled in-vitro systems investigating activin-binding interactions, growth factor signaling pathways, and cellular differentiation models under defined assay conditions. All technical communications are method-centric and do not imply diagnostic, therapeutic, performance, or clinical outcomes in humans or animals.
Ā Ā
ā¢ Research characteristics and applications
Ā Ā Ā Ā Follistatin 344 is characterized by a defined protein structure with high affinity for members of the transforming growth factor-beta (TGF-Ī²) superfamily. In controlled in-vitro environments, researchers employ Follistatin 344 to study ligand-binding dynamics, signaling pathway modulation, and regulatory interactions involving activins and related proteins. Representative applications include assay development, mechanistic pathway investigations, concentration-response analyses, and cellular signaling characterization strictly within laboratory settings.
Ā Ā
ā¢ Manufacturing and documentation
Ā Ā Ā Ā Alpha BioMed Labs manufactures this material in the United States under defined quality procedures and research-only labeling. Certificates of Analysis, raw-material sourcing from vetted suppliers, and complete batch documentation are maintained to support institutional procurement review, traceability, and audit readiness.
Ā Ā
Research Use Only (RUO) Statement
Ā Ā Ā Ā ā¢ For in-vitro research only
Ā Ā Ā Ā ā¢ Not for human or animal consumption
Ā Ā Ā Ā ā¢ Not for diagnostic or therapeutic use
Ā Ā
